- Home
- AKTX vs JZ Comparison
AKTX vs JZ Comparison
Compare AKTX & JZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKTX
- JZ
- Stock Information
- Founded
- AKTX N/A
- JZ 2011
- Country
- AKTX United States
- JZ China
- Employees
- AKTX N/A
- JZ N/A
- Industry
- AKTX Biotechnology: Pharmaceutical Preparations
- JZ Other Consumer Services
- Sector
- AKTX Health Care
- JZ Real Estate
- Exchange
- AKTX Nasdaq
- JZ Nasdaq
- Market Cap
- AKTX 29.1M
- JZ 26.7M
- IPO Year
- AKTX N/A
- JZ 2022
- Fundamental
- Price
- AKTX $1.35
- JZ $0.39
- Analyst Decision
- AKTX
- JZ
- Analyst Count
- AKTX 0
- JZ 0
- Target Price
- AKTX N/A
- JZ N/A
- AVG Volume (30 Days)
- AKTX 32.7K
- JZ 2.6M
- Earning Date
- AKTX 05-19-2025
- JZ 01-01-0001
- Dividend Yield
- AKTX N/A
- JZ N/A
- EPS Growth
- AKTX N/A
- JZ N/A
- EPS
- AKTX N/A
- JZ N/A
- Revenue
- AKTX N/A
- JZ $34,090,704.00
- Revenue This Year
- AKTX N/A
- JZ N/A
- Revenue Next Year
- AKTX N/A
- JZ N/A
- P/E Ratio
- AKTX N/A
- JZ N/A
- Revenue Growth
- AKTX N/A
- JZ N/A
- 52 Week Low
- AKTX $0.85
- JZ $0.51
- 52 Week High
- AKTX $4.40
- JZ $2.34
- Technical
- Relative Strength Index (RSI)
- AKTX 52.00
- JZ 27.37
- Support Level
- AKTX $1.18
- JZ $0.51
- Resistance Level
- AKTX $1.42
- JZ $0.70
- Average True Range (ATR)
- AKTX 0.10
- JZ 0.13
- MACD
- AKTX -0.01
- JZ -0.04
- Stochastic Oscillator
- AKTX 56.67
- JZ 0.18
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.